Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Net Debt Issuances and Repayments: 2014-2015

  • Avadel Pharmaceuticals' Net Debt Issuances and Repayments was N/A to $52.5 billion in Q2 2015 from the same period last year, while for Jun 2015 it was $52.5 billion, marking a year-over-year change of. This contributed to the annual value of $52.5 billion for FY2014, which is N/A change from last year.
  • As of Q2 2015, Avadel Pharmaceuticals' Net Debt Issuances and Repayments stood at $52.5 billion, which was down 0.00% from $52.5 billion recorded in Q1 2015.
  • Avadel Pharmaceuticals' 5-year Net Debt Issuances and Repayments high stood at $52.5 billion for Q4 2014, and its period low was $52.5 billion during Q4 2014.
  • In the last 2 years, Avadel Pharmaceuticals' Net Debt Issuances and Repayments had a median value of $52.5 billion in 2015 and averaged $52.5 billion.